Cargando…
Picropodophyllin (PPP) is a potent rhabdomyosarcoma growth inhibitor both in vitro and in vivo
BACKGROUND: Insulin-like growth factors and insulin are important factors promoting cancer growth and metastasis. The molecules act through IGF1 (IGF1R) and insulin (InsR) receptors. Rhambodmyosarcomas (RMS) overproduce IGF2 – a potent ligand for IGF1R and, at the same time, highly express IGF1 rece...
Autores principales: | Tarnowski, Maciej, Tkacz, Marta, Zgutka, Katarzyna, Bujak, Joanna, Kopytko, Patrycja, Pawlik, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550998/ https://www.ncbi.nlm.nih.gov/pubmed/28793874 http://dx.doi.org/10.1186/s12885-017-3495-y |
Ejemplares similares
-
Differential effect of adenosine on rhabdomyosarcoma migration and proliferation
por: Tarnowski, Maciej, et al.
Publicado: (2018) -
Protein Arginine Methyltransferase (PRMT) Inhibitors—AMI-1 and SAH Are Effective in Attenuating Rhabdomyosarcoma Growth and Proliferation in Cell Cultures
por: Janisiak, Joanna, et al.
Publicado: (2021) -
Adiponectin Is a Component of the Inflammatory Cascade in Rheumatoid Arthritis
por: Łączna, Małgorzata, et al.
Publicado: (2022) -
A Role for Advanced Glycation End Products in Molecular Ageing
por: Zgutka, Katarzyna, et al.
Publicado: (2023) -
Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)
por: Hashemi, Jamileh, et al.
Publicado: (2011)